Barclays cuts Ormat price target as production lags
Two facilities are operating at below full capacity and the investment bank expects earnings to fall as a result.
View ArticleTeva revenue up 33%
However, the pharmaceuticals company missed earnings estimates by $0.01 per share.
View ArticleStrong potash sales boost Israel Chemicals revenue
The company will distribute a $668 million dividend but missed the analysts’ revenue and earnings per share consensus.
View ArticleAmdocs sees weakness in Europe
In its third fiscal quarter, the company missed the revenue consensus but ended ahead on earnings.
View ArticleClik here to view.
Massive offshore reserve holds $45b. in natural gas
Noble Energy: Israel has potential to be gas-exporting nation; Landau: Greatest earnings to be felt by citizens of Israel; GDP increases 4.5%.
View ArticleBarclays sees Tevas share price rising 52%
Barclays expects Teva to report earnings per share of $1.01 for the first quarter and $5.05 for 2011 as a whole.
View ArticleAmdocs reports stronger than expected results
The business support systems company predicts even higher revenue and earnings per share for the third fiscal quarter.
View ArticlePartner Falls to Seven-Week Low as Elbit Drops: Israel Overnight
Partner Communications Co. fell to the lowest level in seven weeks, widening the underperformance for mobile-phone providers relative to the Tel Aviv index, as analysts forecast the company’
View Article
